Paratek Pharmaceuticals, Inc. PRTK
Set alert
2.23 +2.23 —
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 126.02M
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -27.50
- Beta
- 1.71
- Short ratio
- 1.47
- Inst. own
- 52.56%
- Dividend
- 0.00
- Ex-div date
- Oct 30, 2014
- Earnings
- Nov 2, 2023
- 50-d avg
- 1.98
- 200-d avg
- 2.19
- 1y target
- 3.10
3M chart
Events in this range
- Jul 10, 2023Rating: HC Wainwright & Co. · Neutral → Neutral
- Aug 3, 2023Earnings: —; estimate -0.31; surprise —%
Signals (14)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Sep 21, 2023 | 3 years ago |
| SMA: Bullish | Sep 20, 2023 | 3 years ago |
| SMA: Bullish | Sep 20, 2023 | 3 years ago |
| MACD: Sell Signal | Sep 13, 2023 | 3 years ago |
| SMA: Bullish | Sep 5, 2023 | 3 years ago |
| MACD: Buy Signal | Sep 5, 2023 | 3 years ago |
| SMA: Bearish | Sep 1, 2023 | 3 years ago |
| MACD: Sell Signal | Sep 1, 2023 | 3 years ago |
| MACD: Buy Signal | Aug 30, 2023 | 3 years ago |
| SMA: Bullish | Aug 24, 2023 | 3 years ago |
| SMA: Bullish | Aug 24, 2023 | 3 years ago |
| SMA: Bearish | Aug 21, 2023 | 3 years ago |
| SMA: Bearish | Aug 21, 2023 | 3 years ago |
| SMA: Bullish | Aug 18, 2023 | 3 years ago |
Financial health
Altman Z-Score
-9.69 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
4 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -1.6×
FY 2013 5y median -1.6× FY 2022
P/S 0.7×
FY 2013 5y median 6.4× FY 2022
P/B -0.6×
FY 2013 5y median -1.7× FY 2022
P/FCF -1.5×
FY 2013 5y median -2.0× FY 2022
EV/EBITDA -7.3×
FY 2013 5y median -5.6× FY 2022
EV/Sales 2.2×
FY 2013 5y median 5.7× FY 2022
FCF Yield -65.1%
FY 2013 5y median -50.3% FY 2022
Profitability
Gross Margin 84.7%
FY 2013 5y median 82.2% FY 2022
Operating Margin -30.6%
FY 2013 5y median -173.5% FY 2022
Net Margin -42.2%
FY 2013 5y median -267.2% FY 2022
ROE 37.2%
FY 2013 5y median 46.2% FY 2022
ROIC -34.2%
FY 2013 5y median -36.8% FY 2022
ROA -36.8%
FY 2013 5y median -37.4% FY 2022
Growth (YoY)
Revenue 24.7%
FY 2013 FY 2022
Operating Income -12.3%
FY 2013 FY 2022
EPS (diluted) 4.1%
FY 2013 FY 2022
Free Cash Flow -36.0%
FY 2013 FY 2022
Financial Health
Current Ratio 3.7×
FY 2013 5y median 6.9× FY 2022
Quick Ratio 3.2×
FY 2013 5y median 6.2× FY 2022
Debt / Equity -1.5×
FY 2013 5y median -2.0× FY 2022
Net Debt / EBITDA -5.0×
FY 2013 5y median -1.9× FY 2022
Interest Coverage -2.6×
FY 2013 5y median -3.7× FY 2022
Dividends
Dividend Yield 0.0%
FY 2013 5y median 0.0% FY 2022
Payout Ratio 0.0%
FY 2013 5y median 0.0% FY 2022
Annual · latest fiscal year ends 2022-12-31